AI-POWERED
Molecular Design

COMPANY NEWS

January 2025

From publications to technical updates of our Nostrum Suite™ platform, check out our latest in our Newsletter for 2024 Q4

HIGHLIGHT

February 2025

Latest release of PELE 1.9, now featuring PELE Loop Closure, designed to improve the conformational exploration of flexible loops in proteins and RNA

HIGHLIGHT

February 2025

We’re thrilled to announce the opening of our new offices in Boston, USA—a major milestone in our journey

HIGHLIGHT

December 2024

Victor Guallar (CSO) speaking at the DDC Conference, Barcelona, 3-5 Dec

Nostrum Biodiscovery Solutions

Discover

Whether you are focusing on small molecules, enzymes, or biologics, our AI-powered molecular design methods offer the most efficient screening of extensive libraries.

De novo Design

Design your ideal molecule from scratch – whether it is a protein, ligand, enzyme, or nucleic acid. Our advanced active learning generative models, fueled by diverse data sources, ensure unmatched
performance.

Optimize

Leverage our expertise and proprietary platform to optimize any molecule, enhancing its activity, specificity, ADMET properties, and more.

Why Our Solutions Stand Out

We combine our proprietary Molecular Modeling software, with innovative AI tools to deliver highly specialized and efficient solutions.

Technology Publications

Our technology

PELE:

Our proprietary Monte-Carlo based algorithm for molecular modeling

AI algorithms developed for molecular modeling

Passion For Molecules

Thanks to Nostrum Biodiscovery’s atomistic Molecular Modeling, we can tackle any molecular structure.

Small Molecules

Targeted Protein Degradation
Target selection
Hit Finding
Hit to Lead
Lead Optimization

Protein & Peptides

Green Energy
Enzyme Bioprospecitng
Antibody Design
De novo Protein Design
Protein Engineering

Nucleic Acids

Oligonucleotides as drugs
RNA Vaccines
Splicing Modulators
XNA Synthesis Machinery Engineering
High-Performance MD

Nostrum Collaborative Approach

Services

Leave the work to us while you retain full IP rights

Licensing

Leverage our proprietary software with full licensing options

Co Development

Working hand-in-hand and sharing IP

Contact us

Year Founded

Projects Undertaken

Clients

CAGR (2Y)

About

Nostrum Biodiscovery is a spin-off from the Barcelona Supercomputing Center (BSC-CNS) and the Institute for Research in Biomedicine (IRB), two of the most recognized Spanish international research centers.

Our two areas of focus : therapeutics and bio-based chemistry.

Our customer-tailored solutions are based on state-of-the-art proprietary and 3rd-party software, combined with the latest development on AI. We use best in-class Molecular Modeling for data augmentation and fine-tuning of dedicated machine-learning algorithms.

We have now clients in more than 13 countries and are currently expanding in Asia, Latin America while strengthening our presence in the US and Europe.

See the team

News

Technology

Our Polyplat proprietary platform for effective polypharmacology.

See a short presentation on the concept and technologies behind our Polyplat solution.

LINK

Company News

Newsletter
January 2025

Newsletter 2024 Q4

From publications to technical updates of our Nostrum Suite™ platform, it’s all in our latest newsletter.

LINK

Highlight

Thrilled to be part of the Programa Desafia Boston !

We are beyond excited to have been selected for this initiative, which will equip us with the tools, insights, and connections needed to successfully expand our reach in the U.S. market.

LINK
See all news See on

Our clients

Get in touch

Inquiries

For any inquiries, questions, or collaborations, please feel free to reach out to us. You can either call us at the provided number or fill out the contact form, and we will get back to you promptly.

Contact Us


We’re looking for talented people

Come and join us for an exciting job in one of the most innovative and growing biotech in Europe.

Current openings Send us your c.v.
Request a demo
UNIÓN EUROPEA

NOSTRUM BIODISCOVERY, en el marco del programa ICEX NEXT,
cuenta con el apoyo del ICEX y la cofinanciación del fondo europeo
FEDER para su Plan de Entrada en Nuevos Mercados 2020-2024.

CDTI ACCIO Catalonia exponential leader INNOVATIVE SME Cliente ENISA
Shareholders
Barcelona Supercomputing Center Universitat de Barcelona Spinoff ICREA FUNDACIÓN BOTÍN Institute for Research in Biomedicine